Structure-cytotoxicity relationships studies have indicated that the C-3 and C-6 disubstituted piperazine-2,5-diones are structurally required for significant cytotoxicity, and the neihumicin-like C-3 and C-6 disubstituted unsymmetrical piperazine derivatives are, in general, more cytotoxic than the corresponding symmetrical piperazine-2,5-diones. Several synthetic analogs including 3,6-di-(2,4,5-trimethoxybenzylidene)piperazine-2,5-dione, 3,6- dibenzylidene-2-ethoxy-3, 6 -dihydropyrazine-5 -one, 3 -benzylidene-6 -(m-chlorobenzylidene)-2-methoxy-3,6-dihydropyrazin-5-one, and 3 ,6-di-(ra-chlorobenzylidene)-2-methoxy-3 ,6-dihydropyrazin-5-one, have been shownto be more cytotoxic than neihumicin.
Neihumicin produced by Micromonospora neihuensis Wu, sp. nov. is a new cytotoxic antibiotic. The isolation, structural determination and total synthesis have been described in the preceding papers1*23. In this paper, we report on the structure-cytotoxicity relationships of neihumicin and related compounds.
Synthesis of Target Compounds A survey of the literature revealed no record of the systematic structure-cytotoxic antitumor activity relationships study among the piperazine-2,5-dione derivatives. Fig. 1 lists the target compounds we have synthesized for a systematic structure-cytotoxicity correlation among neihumicin (6) related compounds. These compounds were divided into three groups. Group I is piperazinedione without substitution at either C-3 or C-6, such as 2, or with monosubstitution at C-3, such as 3~5 and 7~12. Compounds2~5 are intermediates involved in the total synthesis of 62). An evaluation of this group of compoundswill clarify whether absence of a disubstitution at both C-3 and C-6 of the symmetrical piperazine-2,5-dione skeleton will still lead to potential cytotoxic agents. Group II corresponds to compounds (13~22) with substitution at C-3 and C-6 on piperazine-2,5-diones moieties. Evaluation of this group of compounds will delineate the importance of a disubstitution at C-3 and C-6 for potential cytotoxicity of the symmetrical piperazinedione derivatives. Group III refers to compounds (6 and 23~26) with substitutions C-3 and C-6 on 2-methoxy-3,6-dihydropyrazin-5-one. This will elucidate whether the disubstitution at C-3 and C-6 on an unsymmetrical piperazinedione is the structural requirement for the potent cytotoxicity of 6 and related compounds. The general synthetic scheme of the target compoundsis shown in the Fig. 2 . (Table 1) clearly indicated the importance of the disubstitution at C-3 and C-6 of the piperazine-2,5-dione as the monosubstituted compounds in Group I were all inactive (MIC>4 //g/ml). The C-3, C-6 disubstituted unsymmetrical 2-methoxy-(or 2-ethoxy-)-3,6-dihydropyrazin-5-ones, such as 6 and 25, are in general more cytotoxic than the corresponding symmetrical piperazine-2,5-dione, such as 21 and 14, respectively, except for compounds 26 and 16, in which the latter is more cytotoxic than the former. The degree of cytotoxicity is also obviously dependent on the type of C-3 or C-6 substituents. Thus, amongcompoundsin Group II and Group III only, such as those found in 16, 23, 24, 25 and 26, were most cytotoxic. The nature of the enolized alkyl ether is also important in contributing to the potent cytotoxicity. Thus, 23 is approximately 10-fold more cytotoxic than 6. In vivo screening of these cytotoxic antitumor agents is currently in progress. Expeirmenta l
General
The general experimental details have been reported previously2). 1 ,4-Diacetyl-3-benzylidenepiperazme-2, 5-dione (7) A mixture of 3 (1.22 g, 5 mmol) and 4-dimethylaminopyridine (DMAP)(61 mg) in acetic anhydride (24 ml) was stirred under nitrogen for 24 hours at 40°C. The reaction mixture was allowed to cool to room temperature, poured into ice-water, and extracted with ethyl acetate (3 x l5 ml). The combined organic layers were washed consecutively with cold 5 % aqueous sodium carbonate solution (to neutralize the acetic acid), brine, dried over anhydrous sodium sulfate, and evaporated under vacuum to yield a residue. Chromatography of the residue on silica gel column (22 g, 2 x 17 cm) in chloroform gave fractions which contained 7. Recrystallization from ethanol furnished 7 as colorless needles (1.12 g, 78. (1.03 g, 5 mmol), triethylamine (0.7 ml, 5 mmol) and DMF(10ml) was stirred at room temperature for 3 days. The mixture was APR. 1988 neutralized with acetic acid and poured into water. The product was extracted with ethyl acetate. The organic phase was washed with water, brine, dried over anhydrous magnesiumsulfate, evaporated under vacuum, and gave 8 as pale yellow crystals (1.03 g, 62 %) after recrystallization from methanol: l -Acetyl-3-(2,4,5-trimethoxybenzylidene)piperazine-2,5-dione (9) A mixture of 2 (1.04 g, 5 mmol), 2,4,5-trimethoxybenzaldehyde (1.03 g, 5 mmol), triethylamine (0.7 ml, 5 mmol) and DMF(10 ml) was stirred at room temperature for 2 days. The reaction mixture was neutralized with acetic acid and poured into water. The product was extracted with ethyl acetate. The organic phase was washed with water, brine, dried over anhydrous magnesiumsulfate, evaporated, and yielded 9 (2.51 g, 75%) after recrystallization from methanol: MP 200-202°C; IR 3 ,6-Di-(/7-methylbenzylidene)piperazine-2, 5-dione (13) A mixture of 1 (2.28 g, 20 mmol), p-tolualdehyde (4.8 g, 40 mmol), anhydrous sodium acetate (6.6 g, 80 mmol) and acetic anhydride (12 ml, 127 mmol) was heated for 3 hours at 130-140°C until a solid cake was formed. The reaction mixture was filtered, washed with hot water, ethanol and ether. Recrystallization from acetic acid yield 1. 3 ,6-Diisonicotinylidenepiperazine-2, 5-dione (18) A mixture of 2 (1.98 g, 10 mmol), isonicotinaldehyde (2 ml, 20 mmol), triethylamine (2.8 ml, 20 mmol), and DMF(20 ml) was stirred for 3 days at room temperature. The reaction mixture was concentrated under vacuum. After cooling, the solid was filtered, washed with water, ethanol and dried to give 18 (2.58 g, 88.4%) after recrystallization from acetic acid: MP 302~304°C (dec); IR 3 ,6-Difurfurylidenepiperazine-2,5-dione (19) Compound19 was prepared by use of a procedure identical to that described for preparation of 13. Using furfural (3. 3 ,6-Di-(2-thiophenylidene)piperazine-2,5-dione (20) Compound20 was prepared by the same procedure used to obtain 13. In this case, 2-thiophenecarboxaldehyde (3.7 ml, 40 mmol) was used as the starting material. 3 , 6-Dibenzylidenepiperazine-2, 5-dione (21) A mixture of 2 (4.95 g, 25 mmol), benzaldehyde (6 ml, 59 mmol) and triethylamine (10 ml) in DMF(2.5 ml) was refluxed for 5 hours. The reaction mixture was cooled and the deposited solid broken up, and the mixture was refluxed for 15 hours more. The reaction mixture was then cooled, ethyl acetate added, the crystalline product filtered and washed with more solvent. in dichloromethane (10 ml, 10 mmol) and dichloromethane (10 ml) was stirred at room temperature for 4 days. The reaction mixture was poured into sodiumcarbonate solution and extracted with chloroform. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and evaporated to dryness. The residue (559 mg) was purified by preparative TLC (silica gel, chloroform -«-hexane 3 -Benzylidene-6-(m-chlorobenzylidene)-2-methoxy-3 ,6-dihydropyrazin-5-one (24) To a solution of 5 (108 mg, 0.5 mmol) in dry THF (15 ml) was added n-butyllithium (0.41 ml, 0.65 mmol) at -78°C. After the solution was stirred under argon for 30 minutes, a solution of 3-chlorobenzaldehyde (73.6 /ul, 0.65 mmol) in THF (20 ml), was added dropwise. After the mixture was stirred at -78°C for an additional 1 hour, it was allowed to warm up to 0°C for 20 minutes. The reaction was quenched with saturated aqueous ammoniumchloride (until pH<7)and extracted with ethyl acetate -ether (3 x20 ml). The combined organic layers were washed with brine, water, dried over anhydrous sodium sulfate, evaporated under vacuum, and gave 24 (8. 3 ,6-Di-(/^-chlorobenzylidene)-2-methoxy-3 , 6-dihydropyrazin-5-one (25) A mixture of 14 (1.08 g, 3 mmoi) and trimethyloxonium tetrafluoroborate (2.7 g, 18 mmol) was stirred in dichloromethane (90 ml). After 2 weeks at room temperature, excess of sodium carbonate solution was added and the reaction mixture was extracted with chloroform. The combinedorganic extracts were washed with brine, water, dried over anhydrous magnesiumsulfate, and evaporated under vacuum to yield a residue. This residue was purified by preparative TLC, and gave 25 (60 mg, 3 , 6-Di-(2,4, 5-trimethoxybenzylidene)-2-methoxy-3 , 6-dihydropyrazin-5-one (26) A mixture of 16 (1.7 g, 3.7 mmol) and trimethyloxonium tetrafluoroborate (2 g, 14 mmol) was stirred in dichloromethane (150 ml). After 12 days at room temperature, the reaction mixture was poured into a sodium carbonate solution and extracted with chloroform. The combined organic layers were washed with brine, water, dried over anhydrous magnesiumsulfate and evaporated to dryness. The resulting residue was purified by preparative TLC(silica gel, chloroform -«-hexane, 7 : 3) to give, after crystallization from ethanol, 80 mg (6 % yield) of 26 as orange-red crystals: MP240°C; IR (KBr) 
